Cognition Therapeutics (CGTX) Scheduled to Report Q3 2026 Earnings
Cognition Therapeutics (CGTX) is set to release its third-quarter earnings results on Thursday, November 5th, prior to the market opening. Investors are closely watching for performance metrics as the company prepares to report its latest financial standing. The current consensus EPS estimate for the quarter stands at -$0.07. Recent analyst activity shows a slight positive trend in sentiment, with one upward revision to earnings estimates over the last three months and no downward revisions reported.
Topics: earnings report EPS beat financial results